These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37511917)

  • 1. Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.
    Athar M; Toonsi M; Abduljaleel Z; Bouazzaoui A; Bogari NM; Dannoun A; Al-Allaf FA
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.
    Alnouri F; Al-Allaf FA; Athar M; Al-Rasadi K; Alammari D; Alanazi M; Abduljaleel Z; Awan Z; Bouazzaoui A; Dairi G; Elbjeirami WM; Karra H; Kinsara AJ; Taher MM
    Curr Vasc Pharmacol; 2022; 20(4):361-369. PubMed ID: 35249492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel.
    Rutkowska L; Sałacińska K; Salachna D; Matusik P; Pinkier I; Kępczyński Ł; Piotrowicz M; Starostecka E; Lewiński A; Gach A
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
    Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
    Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Deep Intronic Variant in LDLR in Familial Hypercholesterolemia.
    Reeskamp LF; Hartgers ML; Peter J; Dallinga-Thie GM; Zuurbier L; Defesche JC; Grefhorst A; Hovingh GK
    Circ Genom Precis Med; 2018 Dec; 11(12):e002385. PubMed ID: 30562117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
    Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
    Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.
    Reeskamp LF; Balvers M; Peter J; van de Kerkhof L; Klaaijsen LN; Motazacker MM; Grefhorst A; van Riel NAW; Hovingh GK; Defesche JC; Zuurbier L
    Atherosclerosis; 2021 Mar; 321():14-20. PubMed ID: 33601267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDLR c.89_92dup: a novel frameshift variation in familial hypercholesterolemia.
    Deng J; Zhang J; Meng S; Ding N; Hao Y; Zeng H; Lin J
    Lipids Health Dis; 2024 Jun; 23(1):182. PubMed ID: 38867270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG5 and ABCG8 genetic variants in familial hypercholesterolemia.
    Reeskamp LF; Volta A; Zuurbier L; Defesche JC; Hovingh GK; Grefhorst A
    J Clin Lipidol; 2020; 14(2):207-217.e7. PubMed ID: 32088153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDLR c.415G > A causes familial hypercholesterolemia by weakening LDLR binding to LDL.
    Wang K; Hu T; Tai M; Shen Y; Chai H; Lin S; Chen X
    Lipids Health Dis; 2024 Mar; 23(1):85. PubMed ID: 38515137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.
    Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW
    Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia.
    Lin S; Hu T; Wang K; Wang J; Zhu Y; Chen X
    Lipids Health Dis; 2023 Jun; 22(1):77. PubMed ID: 37340302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis.
    Cao YX; Sun D; Liu HH; Jin JL; Li S; Guo YL; Wu NQ; Zhu CG; Liu G; Dong Q; Sun J; Chen XH; Li JJ
    JACC Asia; 2021 Jun; 1(1):82-89. PubMed ID: 36338372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel LDLR variants affecting low density lipoprotein metabolism identified in familial hypercholesterolemia.
    Wang M; Hong L; Cai L; Zhang Z; Jiang N; Chen Y; Ying Q; Kong L; Wei Z; Xu Y; Jin L
    Mol Biol Rep; 2024 Jan; 51(1):153. PubMed ID: 38236436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
    Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
    Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.